HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy.

Abstract
Vitiligo destroys the melanocytes in the epidermis; the inactive melanocytes in the outer root sheaths are not affected. Phosphatidylcholine liposomes are able to target molecules contained in them into the hair follicles. Khellin is activated by UVA and previous studies have shown that a combination of khellin and UVA (KUVA) can be effective in the treatment of vitiligo. The aim of this study was to determine in an open trial the efficacy and safety of treatment with khellin encapsulated in L-phenylalanine stabilized phosphatidylcholine liposomes in combination with UVA/UVB light therapy(KPLUV) in 74 subjects with vitiligo. After a mean treatment period of 12 months (range 10-14 months) 72% of the treated locations had a repigmentation response of 50% to 100%. Repigmentation of 75-100% was achieved on the face in 63%, the back in 59%, the arms in 58%, the trunk in 57%, the legs in 56% and on the hands in 4% of the patients. Side effects were not seen with KPLUV. The patients in the control group, only treated with UVA/B-light, hardly showed any repigmentation. This indicates that the exposure of the skin to UV light alone is not responsible for the results of KPLUV.
AuthorsJaap de Leeuw, Nick van der Beek, Günther Maierhofer, Wolfgang-Dieter Neugebauer
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2003 Sep-Oct Vol. 13 Issue 5 Pg. 474-7 ISSN: 1167-1122 [Print] France
PMID14693493 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Capsules
  • Liposomes
  • Phosphatidylcholines
  • Vasodilator Agents
  • Phenylalanine
  • Khellin
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Capsules
  • Female
  • Humans
  • Khellin (administration & dosage)
  • Liposomes
  • Male
  • Middle Aged
  • Phenylalanine (administration & dosage)
  • Phosphatidylcholines (administration & dosage)
  • Photochemotherapy (methods)
  • Retrospective Studies
  • Treatment Outcome
  • Ultraviolet Therapy (methods)
  • Vasodilator Agents (administration & dosage)
  • Vitiligo (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: